Cardioversion in atrial fibrillation. Focus on recent-onset atrial fibrillation

Area of Science:

• Cardiology
• Electrophysiology
• Internal Medicine

Background:

• Atrial fibrillation is the most prevalent sustained cardiac arrhythmia.
• Rising prevalence is linked to an aging population and better management of conditions like myocardial infarction and heart failure.
• Recent advancements include novel non-pharmacological therapies, antiarrhythmic drugs, and anticoagulants.

Purpose of the Study:

• To review key practical challenges in managing atrial fibrillation.
• To focus on strategies for patients with recent-onset and hemodynamically stable atrial fibrillation.
• To highlight the critical role of stroke prevention in atrial fibrillation management.

Main Methods:

• Literature review of recent advancements in atrial fibrillation treatment.
• Synthesis of current guidelines and clinical trial data.
• Focus on practical considerations for clinical application.

Main Results:

• Effective non-pharmacological treatments, new antiarrhythmic drugs, and anticoagulants are now available.
• Stroke prevention remains paramount regardless of rate or rhythm control strategy.
• Management requires a tailored approach based on patient-specific factors.

Conclusions:

• Optimal management of atrial fibrillation involves a comprehensive strategy.
• Stroke risk assessment and mitigation are central to patient care.
• This review provides practical insights for clinicians managing hemodynamically stable atrial fibrillation.